Citation

BibTex format

@inproceedings{Sinharay:2018:10.1016/S0169-5002(18)30085-0,
author = {Sinharay, R and Mithra, S and Patel, P and Ah-Moye, A and Morrow, S and Khiroya, R and Falzon, M and Borg, E and Ahmed, T and Forster, M and Navani, N},
doi = {10.1016/S0169-5002(18)30085-0},
pages = {S24--S24},
publisher = {ELSEVIER IRELAND LTD},
title = {EGFR mutation specific immunohistochemistry revolutionises time to treatment with tyrosine kinase inhibitors (TKIs)},
url = {http://dx.doi.org/10.1016/S0169-5002(18)30085-0},
year = {2018}
}
Download

RIS format (EndNote, RefMan)

TY  - CPAPER
AU  - Sinharay,R
AU  - Mithra,S
AU  - Patel,P
AU  - Ah-Moye,A
AU  - Morrow,S
AU  - Khiroya,R
AU  - Falzon,M
AU  - Borg,E
AU  - Ahmed,T
AU  - Forster,M
AU  - Navani,N
DO  - 10.1016/S0169-5002(18)30085-0
EP  - 24
PB  - ELSEVIER IRELAND LTD
PY  - 2018///
SN  - 0169-5002
SP  - 24
TI  - EGFR mutation specific immunohistochemistry revolutionises time to treatment with tyrosine kinase inhibitors (TKIs)
UR  - http://dx.doi.org/10.1016/S0169-5002(18)30085-0
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000424854200060&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
ER  -
Download